Hypercell Technologies Inc. — SEC Form D Filing
Hypercell Technologies Inc. filed an SEC Form D on October 14, 2026, reporting $2.96M raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 14, 2026
- Amount reported
- $2.96M
- Round stage
- Seed, as a $3.0 million equity offering is the standard size for early-stage biotechnology commercialization and field validation.
- Industry
- Biotechnology
- Website
- https://hypercelltech.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Food and agriculture supply chains suffer from delayed pathogen detection and quality control processes that lead to costly contamination outbreaks and food waste.
Solution
Hypercell Technologies builds point-of-care biotechnology diagnostics to rapidly detect biological pathogens and manage safety across the food, beverage, and agriculture sectors.
Why now
Tightening food safety regulations and heightened supply chain vulnerability require real-time biological screening over traditional days-long offsite lab testing.
Source: SEC EDGAR Form D filing